Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach

Sulfonylureas (SU) continue to be a vital therapeutic category of oral hypoglycemic agents (OHAs) for the management of type 2 diabetes mellitus (T2DM). Physicians consider modern SU (gliclazide and glimepiride) as “safe and smart” choices for T2DM management. The presence of multiple international...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Ashok Kumar, Saboo, Banshi, Chawla, Rajeev, Aravind, S. R., Rajput, Rajesh, Singh, Awadhesh K., Mukherjee, J. J., Jhingan, Ashok, Shah, Parag, Deshmukh, Vaishali, Kale, Shailaja, Jaggi, Shalini, Sridhar, G. R., Dhediya, Rajnish, Gaurav, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2023
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113130/
https://www.ncbi.nlm.nih.gov/pubmed/37360324
http://dx.doi.org/10.1007/s13410-023-01192-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113130/
https://www.ncbi.nlm.nih.gov/pubmed/37360324
http://dx.doi.org/10.1007/s13410-023-01192-6

Ejemplares similares